Early response with fezolinetant treatment of moderate-to-severe vasomotor symptoms associated with menopause: pooled data from two randomized Phase 3 studies

被引：0

作者：

Shapiro, C. M. Marla ^{[1
]}

Neal-Perry, Genevieve ^{[2
]}

Stute, Petra ^{[3
]}

Thurston, Rebecca C. ^{[4
]}

Wolfman, Wendy ^{[1
]}

English, Marci ^{[5
]}

Zhao, Jun ^{[5
]}

Ottery, Faith D. ^{[5
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] UNC, Sch Med, Chapel Hill, NC USA

[3] Inselspital Bern, Bern, Switzerland

[4] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA

[5] Astellas Pharma Global Dev Inc, Northbrook, IL USA

来源：

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2022年 / 29卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-73

引用

页码：1483 / 1484

页数：2